Associations between Prediagnostic Circulating Bilirubin Levels and Risk of Gastrointestinal Cancers in the UK Biobank
Open Access
Abstract
We investigated associations between serum levels of bilirubin, an endogenous antioxidant, and gastrointestinal cancer risk. In the UK Biobank, prediagnostic serum levels of total bilirubin were measured in blood samples collected from 440,948 participants. In multivariable-adjusted Cox proportional hazard regression, we estimated hazard ratios (HR) and 95% confidence intervals (CI) for associations between bilirubin levels and gastrointestinal cancer risk (colorectum, esophagus, stomach, mouth, pancreas, and liver). After a median follow-up of 7.1 years (interquartile range: 1.4), 5033 incident gastrointestinal cancer cases were recorded. In multivariable-adjusted models, bilirubin levels were negatively associated with risk of esophageal adenocarcinoma (EAC, HR per 1-SD increment in log-total bilirubin levels 0.72, 95%CI 0.56–0.92, p = 0.01). Weak and less robust negative associations were observed for colorectal cancer (CRC, HR per 1-SD increment in log-total bilirubin levels 0.95, 95%CI 0.88–1.02, p = 0.14). Bilirubin levels were positively associated with risk of hepatocellular carcinoma (HCC, HR per 1-SD increment in log-total bilirubin levels 2.07, 95%CI 1.15–3.73, p = 0.02) and intrahepatic bile duct (IBD) cancer (HR per 1-SD increment 1.67, 95%CI 1.07–2.62, p = 0.03). We found no associations with risks of stomach, oral, and pancreatic cancers. Prediagnostic serum levels of bilirubin were negatively associated with risk of EAC and positively associated with HCC and IBD cancer. Further studies are warranted to replicate our findings for specific GI cancers.Keywords
Funding Information
- Austrian Science Fund (FWF) (29608)
- French National Cancer Institute (INCa) (2016-043)
This publication has 45 references indexed in Scilit:
- Bilirubin and Related Tetrapyrroles Inhibit Food-Borne Mutagenesis: A Mechanism for Antigenotoxic Action against a Model EpoxideJournal of Natural Products, 2013
- In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cellsExperimental Cell Research, 2013
- Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assayToxicology in Vitro, 2013
- In vitroantioxidant capacity and antigenotoxic properties of protoporphyrin and structurally related tetrapyrrolesFree Radical Research, 2012
- High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer riskInternational Journal of Oncology, 2012
- Acute liver failure: mechanisms of immune-mediated liver injuryLiver International, 2010
- Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancerInternational Journal of Cancer, 2010
- Mechanism of Gender-Divergent UDP-Glucuronosyltransferase mRNA Expression in Mouse Liver and KidneyDrug Metabolism and Disposition, 2009
- Bilirubin and glutathione have complementary antioxidant and cytoprotective rolesProceedings of the National Academy of Sciences, 2009
- Antioxidant supplements for preventing gastrointestinal cancersCochrane Database of Systematic Reviews, 2008